Sentence examples for bowel dysfunction in the from inspiring English sources

Existing survey instruments for bowel dysfunction in the pediatric population are either parent-reported or focus on non-neurogenic bowel dysfunction.

This text reviews the anatomy and physiology of neuromodulation for treatment of various pathology of the human body, with specific emphasis on sacral neuromodulation for bladder and bowel dysfunction in the adult and pediatric populations.

Management of bladder and bowel dysfunction in the elderly is currently far from ideal and also carries a significant financial burden.

Early transition to enteral nutrition was attempted as soon as possible if the cardiopulmonary function of the patient was stable, and unless there was bowel dysfunction in the patient.

Tablet-based data capture and automated continence referral using the TaDiMuS system is an efficient, sensitive, and feasible method of screening MS patients for bladder and bowel dysfunction in the clinic setting.

Because the spinal cord contains both autonomic and somatic motoneurons that regulate bladder and bowel function (refer to previous sections) then studies of age-associated changes to these neurons may be key to understanding neurogenic forms of bladder and bowel dysfunction in the elderly.

Gastric dysfunction is more important than small bowel dysfunction in this model.

We present the final results of a multicentric prospective study to evaluate the effect of SNM in the management of urinary incontinence and bowel dysfunction in children.

In addition, the sizeable number of incontinence instruments available and the large volume of incontinence research to date indicate that faecal incontinence has been the main focus of bowel dysfunction in general.

Methylnaltrexone recently received approval by the US Food and Drug Administration FDAandand the European Medicines Agency for treatment of opioid-related bowel dysfunction in patients with advanced illness.

4 The treatment with OXN-PR did not worsen bowel dysfunction in our patients, even in those subjects with manifest constipation at baseline, with a nonsignificant decrease from baseline in the proportion of patients complaining of constipation after 28 days of treatment and without an increase in laxative consumption.